Literature DB >> 15368529

Characterization and crystal structure of D-mannitol hemihydrate.

Cletus Nunes1, Raj Suryanarayanan, Cristian E Botez, Peter W Stephens.   

Abstract

The objectives of this study were (i) to isolate and characterize mannitol hydrate, and (ii) to solve its crystal structure from high-resolution synchrotron X-ray powder diffraction data. Mannitol hydrate was prepared by freeze-drying aqueous mannitol solutions (5% w/v) under controlled conditions. X-ray powder diffractometry, differential scanning calorimetry, and thermogravimetric analyses indicated that mannitol exists as a hemihydrate (C(6)H(14)O(6) . 0.5H(2)O). Synchrotron data were collected on the X3B1 beamline at the National Synchrotron Light Source. The simulated annealing program PSSP was used to solve the structure, which was subsequently refined by Rietveld analysis using the program package GSAS. The compound crystallizes in space group P1, with a = 9.8963 A, b = 10.5424 A, c = 4.7860 A, alpha = 102.589 degrees , beta = 86.092 degrees , and gamma = 116.079 degrees . The unit cell contains two dissimilar D-mannitol molecules and one water molecule, forming a hydrogen bonding pattern significantly different from that seen in the anhydrous polymorphs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15368529     DOI: 10.1002/jps.20185

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  13 in total

1.  Influence of ethanol on physical state of freeze-dried mannitol.

Authors:  Akira Takada; Steven L Nail; Masakatsu Yonese
Journal:  Pharm Res       Date:  2009-01-28       Impact factor: 4.200

2.  Design, characterization, and aerosol dispersion performance modeling of advanced spray-dried microparticulate/nanoparticulate mannitol powders for targeted pulmonary delivery as dry powder inhalers.

Authors:  Xiaojian Li; Frederick G Vogt; Don Hayes; Heidi M Mansour
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2014-02-06       Impact factor: 2.849

3.  Characterization of spray dried powders with nucleic acid-containing PEI nanoparticles.

Authors:  Tobias W M Keil; Daniel P Feldmann; Gabriella Costabile; Qian Zhong; Sandro da Rocha; Olivia M Merkel
Journal:  Eur J Pharm Biopharm       Date:  2019-08-21       Impact factor: 5.571

4.  Effect of Particle Formation Process on Characteristics and Aerosol Performance of Respirable Protein Powders.

Authors:  Ashlee D Brunaugh; Tian Wu; Sekhar R Kanapuram; Hugh D C Smyth
Journal:  Mol Pharm       Date:  2019-08-26       Impact factor: 4.939

5.  Formulation for a novel inhaled peptide therapeutic for idiopathic pulmonary fibrosis.

Authors:  Soraya Hengsawas Surasarang; Galina Florova; Andrey A Komissarov; Sreerama Shetty; Steven Idell; Robert O Williams
Journal:  Drug Dev Ind Pharm       Date:  2017-11-10       Impact factor: 3.225

6.  Solute crystallization in frozen systems-use of synchrotron radiation to improve sensitivity.

Authors:  Dushyant B Varshney; Satyendra Kumar; Evgenyi Y Shalaev; Shin-Woong Kang; Larry A Gatlin; Raj Suryanarayanan
Journal:  Pharm Res       Date:  2006-08-23       Impact factor: 4.200

7.  Nanobubbles in Reconstituted Lyophilized Formulations: Interaction With Proteins and Mechanism of Formation.

Authors:  Jared R Snell; N S Krishna Kumar; Raj Suryanarayanan; Theodore W Randolph
Journal:  J Pharm Sci       Date:  2019-05-13       Impact factor: 3.534

8.  Raman mapping of mannitol/lysozyme particles produced via spray drying and single droplet drying.

Authors:  Jari Pekka Pajander; Sanni Matero; Jakob Sloth; Feng Wan; Jukka Rantanen; Mingshi Yang
Journal:  Pharm Res       Date:  2014-12-13       Impact factor: 4.200

9.  Influence of process conditions on the crystallization and transition of metastable mannitol forms in protein formulations during lyophilization.

Authors:  Wenjin Cao; Yong Xie; Sampathkumar Krishnan; Hong Lin; Margaret Ricci
Journal:  Pharm Res       Date:  2012-08-21       Impact factor: 4.200

10.  Characterization of mannitol polymorphic forms in lyophilized protein formulations using a multivariate curve resolution (MCR)-based Raman spectroscopic method.

Authors:  Yong Xie; Wenjin Cao; Sampathkumar Krishnan; Hong Lin; Nina Cauchon
Journal:  Pharm Res       Date:  2008-06-04       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.